How many studies have been conducted on Plicamycin?

BiohacksAI has indexed 72 PubMed studies on Plicamycin, including 1 randomized controlled trials (RCTs). 58% of studies involve human subjects.

What are the main research areas for Plicamycin?

The primary research domains for Plicamycin are 🔬 Oncology, 😴 Sleep, 🧬 Hormones. This is based on analysis of 72 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Plicamycin

A tricyclic pentaglycosidic antibiotic from Streptomyces strains that inhibits RNA and protein synthesis by adhering to DNA. It is used as a fluorescent dye and as an antineoplastic agent, especially in bone and testicular tumors. Plicamycin is also used to reduce hypercalcemia, especially that due to malignancies.

72+ PubMed studies analyzed · 1 RCTs · Evidence Score: 44.9

Research Domains

Plicamycin has been studied across 17 research domains including 🔬 Oncology, 😴 Sleep, 🧬 Hormones, 🔬 Inflammation, 🦴 Bone & Joint. The primary research focus is 🔬 Oncology with 51% of studies addressing this area.

Loading evidence profile...

This evidence profile for Plicamycin is generated deterministically from 72 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.